Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T12:45:52.260Z.
Calculation as of: 2026-10-06T12:45:52.260Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cf0630fc9642b75147419b140bafddb7ccff0a2362c2d95f2dd7172ee2000ae5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$922.50M
Operating Cash Flow Yield
N/A
TTM Avg
8.30%
3Y Avg
22.27%
5Y Avg
22.27%
Market Cap
$921.45M
Operating Cash Flow Yield
7.79%
TTM Avg
8.82%
3Y Avg
7.69%
5Y Avg
7.20%
Market Cap
$915.95M
Operating Cash Flow Yield
10.58%
TTM Avg
11.28%
3Y Avg
6.74%
5Y Avg
6.11%
Market Cap
$903.13M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$989.05M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Operating Cash Flow Yield
N/A
TTM Avg
10.89%
3Y Avg
10.89%
5Y Avg
10.89%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CeriBell, Inc. (CBLL) | $943.26M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | N/A | 8.30% | 22.27% | 22.27% |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 7.79% | 8.82% | 7.69% | 7.20% |
| Bioventus Inc. (BVS)vs › | $915.95M | 10.58% | 11.28% | 6.74% | 6.11% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $989.05M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | N/A | 10.89% | 10.89% | 10.89% |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 8.26% | 7.29% | 7.32% | 6.78% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
